This speculation is supported by the results of our previous study showing that treatment of tumor-bearing rats with a column that adsorbs TGF-β resulted in prolonged survival [20] and the results of another study showing that reduction of LAP+ cells by administration of an anti-LAP antibody activated anti-tumor immunity in tumor-bearing mice [21]. This evidence concerns the gene TGFB1 and neoplasm.